P.E.I.’s Chief Public Health Officer is working towards expanding eligibility for RSV vaccines as the province experiences ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...

A new study is showing a policy change in 2016 related to the vaccination of some premature babies for RSV in Nova Scotia led ...

Halton Healthcare’s first regional Paediatric RSV immunization clinic has officially closed after immunizing 500 babies ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Two RSV vaccines were approved for use in Australia last year by the Therapeutic Goods Administration. The Australian Government is funding Pfizer’s Abrysvo for pregnant women and, in an unusual ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

As new viruses like COVID-19, bird flu, norovirus, and RSV (respiratory syncytial virus) continue to spread, vaccines have ...